Opus Genetics, Inc. IRD
- RYZUMVI — Pharmacologically Induced Mydriasis Approved
- RYZUMVI — Presbyopia NDA Submitted
- RYZUMVI — Vision Disturbances After Keratorefractive Surgery Phase 3
Home › Targets › alpha-2 adrenergic receptor
alpha-2 adrenergic receptor (1 companies · 3 programs)
Companies with an active program directed at alpha-2 adrenergic receptor.